Valuation Challenges for Early-Stage Companies

The Need for Future Equity or Debt Contributions Introduces Complexities into the Business Valuation Process

By Carl Saba, BPM Shareholder

This white paper discusses the issue of how to best reflect the impact of future rounds of equity or debt financings in the valuation of an equity interest in an early stage technology or life sciences company.

The white paper also discusses how to address this issue of future financings in the context of commonly used methods for allocating equity value to complex capital structures. These methods include the Option Pricing Method and the Probability Weighted Expected Return Method. Both methods look beyond the valuation date to an ultimate liquidity event, and require different approaches to address future financings that will occur after the valuation date.